156 related articles for article (PubMed ID: 9631606)
1. A case of primary non-Hodgkin's lymphoma of the uterine cervix treated by combination chemotherapy (THP-COP).
Nasu K; Yoshimatsu J; Urata K; Miyakawa I
J Obstet Gynaecol Res; 1998 Apr; 24(2):157-60. PubMed ID: 9631606
[TBL] [Abstract][Full Text] [Related]
2. [Primary diffuse large B-cell lymphoma of the uterine cervix successfully treated with rituximabplus cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy-a case report].
Hashimoto A; Fujimi A; Kanisawa Y; Matsuno T; Okuda T; Minami S; Doi T; Ishikawa K; Uemura N; Jyomen Y; Tomaru U
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2589-92. PubMed ID: 24335377
[TBL] [Abstract][Full Text] [Related]
3. Primary non-Hodgkin's lymphoma of the uterine cervix successfully treated by neoadjuvant chemotherapy: case report.
Szánthó A; Bálega J Já; Csapó Z; Sréter L Lí; Matolcsy A; Papp Z
Gynecol Oncol; 2003 Apr; 89(1):171-4. PubMed ID: 12694673
[TBL] [Abstract][Full Text] [Related]
4. [A case of primary hepatic lymphoma successfully treated by THP-COP therapy].
Takauchi K; Kono H; Ito T; Zaima K; Okumoto S
Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):65-8. PubMed ID: 12649851
[TBL] [Abstract][Full Text] [Related]
5. R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
Hara T; Yoshikawa T; Goto H; Sawada M; Yamada T; Fukuno K; Kasahara S; Shibata Y; Matsumoto T; Mabuchi R; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Nannya Y; Katsumura N; Takahashi T; Kito Y; Takami T; Miyazaki T; Takeuchi T; Shimizu M; Tsurumi H
Hematol Oncol; 2018 Oct; 36(4):638-644. PubMed ID: 29882279
[TBL] [Abstract][Full Text] [Related]
6. Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.
Goto N; Tsurumi H; Goto H; Shimomura YI; Kasahara S; Hara T; Yasuda I; Shimizu M; Murakami N; Yoshikawa T; Fukuno K; Takahashi T; Kito Y; Takami T; Moriwaki H
Ann Hematol; 2012 May; 91(5):705-714. PubMed ID: 22183251
[TBL] [Abstract][Full Text] [Related]
7. Malignant lymphoma of the uterine cervix: a case report and review of literature.
Biswal BM; Sharma A; Sharma MC; Prasad RR; Roy K; Rath GK
J Indian Med Assoc; 1997 Jul; 95(7):434, 440. PubMed ID: 9425847
[No Abstract] [Full Text] [Related]
8. 3A Comparison between R-THP-COP and R-CHOP Regimens for the Treatment of Diffuse Large B-cell Lymphoma in Old Patients: A Single-institution Analysis.
Araie H; Sakamaki I; Matsuda Y; Tai K; Ikegaya S; Itoh K; Kishi S; Oiwa K; Okura M; Tasaki T; Hosono N; Ueda T; Yamauchi T
Intern Med; 2017 Sep; 56(18):2407-2413. PubMed ID: 28824057
[TBL] [Abstract][Full Text] [Related]
9. Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report.
Cubo AM; Soto ZM; Cruz MÁ; Doyague MJ; Sancho V; Fraino A; Blanco Ó; Puig N; Alcoceba M; González M; Sayagués JM
Medicine (Baltimore); 2017 May; 96(19):e6846. PubMed ID: 28489772
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of rituximab combined with pirarubicin-cyclophosphamide, vincristine and prednisolone regimen as first-line therapy for patients with indolent B-cell lymphoma.
Tsurumi H; Hara T; Goto N; Kitagawa J; Kanemura N; Yoshikawa T; Kasahara S; Goto H; Fukuno K; Yamada T; Sawada M; Shimizu M; Takahashi T; Takami T; Moriwaki H
Leuk Lymphoma; 2012 Feb; 53(2):247-53. PubMed ID: 21827339
[TBL] [Abstract][Full Text] [Related]
11. [Life-Threatening Hyponatremia by Chemotherapy in a Patient with Non-Hodgkin's Lymphoma].
Morikawa G; Kinjo T; Hanaoka Y; Kiyono T; Okazawa K; Dan K
Gan To Kagaku Ryoho; 2015 Dec; 42(13):2493-6. PubMed ID: 26809312
[TBL] [Abstract][Full Text] [Related]
12. Primary non-Hodgkin's lymphoma presenting as a uterine cervical mass.
Ab Hamid S; Wastie ML
Singapore Med J; 2008 Mar; 49(3):e73-5. PubMed ID: 18362991
[TBL] [Abstract][Full Text] [Related]
13. Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study.
Tsurumi H; Yamada T; Sawada M; Kasahara S; Kanemura N; Kojima Y; Fukuno K; Hara T; Saio M; Takahashi T; Oyama M; Ozawa K; Takami T; Moriwaki H
J Cancer Res Clin Oncol; 2004 Feb; 130(2):107-13. PubMed ID: 14648210
[TBL] [Abstract][Full Text] [Related]
14. Results of a randomized phase III trial in children and adolescents with advanced stage diffuse large cell non Hodgkin's lymphoma: a Pediatric Oncology Group study.
Laver JH; Mahmoud H; Pick TE; Hutchinson RE; Weinstein HJ; Schwenn M; Weitzman S; Murphy SB; Ochoa S; Shuster JJ;
Leuk Lymphoma; 2001 Jul; 42(3):399-405. PubMed ID: 11699405
[TBL] [Abstract][Full Text] [Related]
15. A high serum-soluble interleukin-2 receptor level is associated with a poor outcome of aggressive non-Hodgkin's lymphoma.
Niitsu N; Iijima K; Chizuka A
Eur J Haematol; 2001 Jan; 66(1):24-30. PubMed ID: 11168504
[TBL] [Abstract][Full Text] [Related]
16. Pirarubicin, a novel derivative of doxorubicin. THP-COP therapy for non-Hodgkin's lymphoma in the elderly.
Kitamura K; Takaku F
Am J Clin Oncol; 1990; 13 Suppl 1():S15-9. PubMed ID: 2291455
[TBL] [Abstract][Full Text] [Related]
17. [Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival].
Chubachi A; Miura AB; Yamaguchi A; Nishimura S
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2057-63. PubMed ID: 3293535
[TBL] [Abstract][Full Text] [Related]
18. [Testicular malignant lymphoma: a case report].
Takeuchi Y; Sawada Y; Yabuki D; Masuda E; Satou D; Iwasawa T; Kuroda K; Tajima M; Matsushima M
Hinyokika Kiyo; 2003 Nov; 49(11):675-8. PubMed ID: 14719457
[TBL] [Abstract][Full Text] [Related]
19. Primary diffuse large B cell lymphoma of Uterine Cervix: Treatment outcomes of a rare entity with literature review.
Goda JS; Gaikwad U; Narayan A; Kurkure D; Yadav S; Khanna N; Jain H; Bagal B; Epari S; Singh P; Sengar M; Laskar S
Cancer Rep (Hoboken); 2020 Oct; 3(5):e1264. PubMed ID: 32761885
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy with pirarubicin (THP), cyclophosphamide, vincristine, and prednisolone (VEP-THP therapy) in the treatment of non-Hodgkin's lymphoma.
Takagi T; Sakai C; Oguro M
Oncology; 1990; 47(1):25-8. PubMed ID: 2300381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
